Added to YB: 2021-11-15
Pitch date: 2021-11-15
AXSM [bullish]
Axsome Therapeutics, Inc.
+386.6%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
Market Cap
$9.2B
Pitch Price
$38.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
-49.67
P/E
-39.31
EV/Sales
16.27
Sector
Pharmaceuticals
Category
N/A
Show full summary:
AXSOME THERAPEUTICS INC AXSM
A summary for this pitch has not been created yet.
Read full article (0 min)